PKN1
Serine/threonine-protein kinase N1
Also known as: DBK, MGC46204, PAK1, PKN, PKN1_HUMAN, PRK1, PRKCL1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16512
- Gene
- PKN1
- Ensembl
- ENSG00000123143
- Chromosome
- 19
- Canonical length
- 942 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytokinetic bridge
OverviewNCBI Gene
The protein encoded by this gene belongs to the protein kinase C superfamily. This kinase is activated by Rho family of small G proteins and may mediate the Rho-dependent signaling pathway. This kinase can be activated by phospholipids and by limited proteolysis. The 3-phosphoinositide dependent protein kinase-1 (PDPK1/PDK1) is reported to phosphorylate this kinase, which may mediate insulin signals to the actin cytoskeleton. The proteolytic activation of this kinase by caspase-3 or related proteases during apoptosis suggests its role in signal transduction related to apoptosis. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
942 residues, UniProt reviewed canonical sequence.
>Q16512|PKN1
1 MASDAVQSEP RSWSLLEQLG LAGADLAAPG VQQQLELERE RLRREIRKEL KLKEGAENLR
61 RATTDLGRSL GPVELLLRGS SRRLDLLHQQ LQELHAHVVL PDPAATHDGP QSPGAGGPTC
121 SATNLSRVAG LEKQLAIELK VKQGAENMIQ TYSNGSTKDR KLLLTAQQML QDSKTKIDII
181 RMQLRRALQA GQLENQAAPD DTQGSPDLGA VELRIEELRH HFRVEHAVAE GAKNVLRLLS
241 AAKAPDRKAV SEAQEKLTES NQKLGLLREA LERRLGELPA DHPKGRLLRE ELAAASSAAF
301 STRLAGPFPA THYSTLCKPA PLTGTLEVRV VGCRDLPETI PWNPTPSMGG PGTPDSRPPF
361 LSRPARGLYS RSGSLSGRSS LKAEAENTSE VSTVLKLDNT VVGQTSWKPC GPNAWDQSFT
421 LELERARELE LAVFWRDQRG LCALKFLKLE DFLDNERHEV QLDMEPQGCL VAEVTFRNPV
481 IERIPRLRRQ KKIFSKQQGK AFQRARQMNI DVATWVRLLR RLIPNATGTG TFSPGASPGS
541 EARTTGDISV EKLNLGTDSD SSPQKSSRDP PSSPSSLSSP IQESTAPELP SETQETPGPA
601 LCSPLRKSPL TLEDFKFLAV LGRGHFGKVL LSEFRPSGEL FAIKALKKGD IVARDEVESL
661 MCEKRILAAV TSAGHPFLVN LFGCFQTPEH VCFVMEYSAG GDLMLHIHSD VFSEPRAIFY
721 SACVVLGLQF LHEHKIVYRD LKLDNLLLDT EGYVKIADFG LCKEGMGYGD RTSTFCGTPE
781 FLAPEVLTDT SYTRAVDWWG LGVLLYEMLV GESPFPGDDE EEVFDSIVND EVRYPRFLSA
841 EAIGIMRRLL RRNPERRLGS SERDAEDVKK QPFFRTLGWE ALLARRLPPP FVPTLSGRTD
901 VSNFDEEFTG EAPTLSPPRD ARPLTAAEQA AFLDFDFVAG GCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PKN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 86 nTPM
Expression across tissuesHPA
Tissue
- spleen: 86 nTPM
- heart muscle: 83 nTPM
- skeletal muscle: 78 nTPM
- colon: 69 nTPM
- lung: 67 nTPM
- bone marrow: 63 nTPM
Single-cell type
- hofbauer cells: 114 nCPM
- nk-cells: 98 nCPM
- kupffer cells: 95 nCPM
- alveolar cells type 1: 90 nCPM
- monocytes: 90 nCPM
- neutrophil progenitors: 87 nCPM
Immune cell
- non-classical monocyte: 53 nTPM
- eosinophil: 41 nTPM
- intermediate monocyte: 38 nTPM
- neutrophil: 32 nTPM
- gdT-cell: 30 nTPM
- total PBMC: 29 nTPM
Brain region
- medulla oblongata: 95 nTPM
- spinal cord: 88 nTPM
- pons: 88 nTPM
- cerebral cortex: 88 nTPM
- basal ganglia: 87 nTPM
- midbrain: 86 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.2
- gnomAD missense Z
- 1.34
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell apoptotic process
- B cell homeostasis
- epithelial cell migration
- hyperosmotic response
- intracellular signal transduction
- negative regulation of B cell proliferation
- post-translational protein modification
- protein phosphorylation
- regulation of androgen receptor signaling pathway
- regulation of cell motility
- regulation of germinal center formation
- regulation of immunoglobulin production
- regulation of transcription by RNA polymerase II
- renal system process
- signal transduction
- spleen development
Molecular functions
- ATP binding
- chromatin binding
- diacylglycerol-dependent serine/threonine kinase activity
- histone binding
- histone deacetylase binding
- histone H3T11 kinase activity
- nuclear androgen receptor binding
- protein kinase activity
- protein kinase C binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- small GTPase binding
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Protein kinase domain
- AGC-kinase, C-terminal
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- HR1 rho-binding domain
- Protein kinase, ATP binding site
- Protein kinase, C-terminal
- C2 domain superfamily
- HR1 repeat superfamily
- Serine/threonine-protein kinase N, first HR1 domain
- Serine/threonine-protein kinase N, C2 domain
- Protein kinase domain
- Protein kinase C terminal domain
- Hr1 repeat
- Serine/threonine-protein kinase N1, second HR1 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PKN1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PKN1 as an antibody target. Whether an autoantibody or antibody against PKN1 could matter depends on whether native PKN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PKN1 is annotated at the cell surface, where native PKN1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PKN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...